The novel target of esophageal squamous cell carcinoma: lncRNA GASL1 regulates cell migration, invasion and cell cycle stagnation by inactivating the Wnt3a/β-catenin signaling-Reference-Cited by-同舟云学术

The novel target of esophageal squamous cell carcinoma: lncRNA GASL1 regulates cell migration, invasion and cell cycle stagnation by inactivating the Wnt3a/β-catenin signaling

Published:2021-01 Issue: Volume:217 Page:153289
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Ren Yuanyuan,Guo Ting,Xu Jie,Liu Yongbiao,Huang Junxing

Funder

Jiangsu Provincial Medical Innovation Team

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference24 articles.

1. TNFAIP8 regulates cisplatin resistance through TAF-Ialpha and promotes malignant progression of esophageal cancer;Zhang;Eur. Rev. Med. Pharmacol. Sci.,2020

2. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA;Qiu;Aging (Albany NY).,2020

3. Hydroxysafflor yellow a of Carthamus tinctorius L., represses the malignant development of esophageal Cancer cells via regulating NF-kappaB signaling pathway;Chen;Cell Biochem. Biophys.,2020

4. Higher doses of neoadjuvant radiation for esophageal Cancer Do not affect the pathologic complete response rate or survival: a propensity-matched analysis;Worrell;Ann. Surg. Oncol.,2020

5. LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to miR-498;Jin;Neoplasma.,2020

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of the lncRNA/Wnt signaling pathway in digestive system cancer: a literature review;European Journal of Medical Research;2024-09-02

2. Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics;Cancers;2023-10-20

3. PHGDH promotes esophageal squamous cell carcinoma progression via Wnt/β-catenin pathway;Cellular Signalling;2023-09

4. Downregulation of MAL2 inhibits breast cancer progression through regulating β-catenin/c-Myc axis;Cancer Cell International;2023-07-21

5. Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies;MedComm;2023-07-10